Skip to main content
. 2020 Sep 24;13:571–582. doi: 10.2147/JIR.S266995

Figure 4.

Figure 4

A438079 prevented the development of morphine antinociceptive tolerance and inhibited the morphine-tolerant-induced upregulation of NLRP3. (A) Western blot showing the expression of P2X7R and NLRP3 in the spinal cord of mice treated with saline (CON), morphine (MOR), A438079+morphine (A+MOR) and A438079. (B) Columns and errors are presented as mean ± SEM; n = 6, **p<0.01, ***p < 0.001. (C) The withdrawal latencies of WT mice treated with morphine, A438079+morphine or 25%DMSO+Morphine before and 30 min after morphine treatment. (D) The %MPE of WT mice treated with morphine or A438079+morphine on days 1 and 7. Columns and errors are presented as mean ± SEM; n = 6, ***p<0.001. (E) Repeated morphine treatment produced a significant rightward shift in the morphine dose-response curve on day 8. A438079 pretreated mice showed elevated response to morphine, and morphine response curve was shifted to the left. The ID50 of morphine in mice treated with morphine and treated with A438079+morphine on day8 were 29.04 ug and 7.254ug (n=6). (F) P2X7R (red) colocalization with Iba1 (green) in the dorsal horn of spinal cord of WT mice treated with morphine.